-
Salleras Ll. Vacunaciones Preventivas: Principios y Aplicaciones. Ed. Masson
S.A. Barcelona, 1998.
-
Plotkin SA, Orenstein WA.
(Eds). Vaccines 3ª ed. Saunders Company. Philadelphia 1999.
-
The Pediatric Clinics of North America: Childhood Immunizations 2000, 47:2.
WB Saunders Co. Philadelphia 2000.
-
Comité Asesor de Vacunas de la Asociación Española de Pediatría. Manual de
Vacunas en Pediatría. Edición 2001. Madrid. 2001.
-
Comité Asesor de Vacunas de la Asociación Española de Pediatría. Calendario
Vacunal de la Asociación Española de Pediatría 1999. An Esp Pediatr
1999;51:120-126.
-
Comité Asesor de Vacunas de la Asociación Española de Pediatría. Calendario
Vacunal de la Asociación Española de Pediatría 2001-2002. An Esp Pediatr
2001;55:30-38.
-
American Academy of Pediatrics. Active and passive immunization. In:
Pickering LK ed. 2000 Red Book: report of the Commitee on Infectious
Diseases. 25th ed. Elk Grove Village, IL. American Academy of Pediatrics.
2000:1-81.
-
CDC. General recomendations on immunization: recomendations of the Advisory
Comittee on Immunization Practices (ACIP). MMWR 1994;43(No.RR-1):1-38
-
CDC. Update: Vaccine Side Effects, Adverse Reactions, Contraindications and
Precautions. Recommendations of the Advisory Committee on Immunization
Practices. MMWR 1996; 45(RR13):1-16.
-
American Academy of Pediatrics. Committee on Infectious Diseases. Recomended
Childhood Immunization Schedule-United States. January-December 2000.
Pediatrics 2000;105:148-151.
-
CDC. Recommended Childhood Immunization Schedule - United States, 2001. MMWR
2001;50(RR-01):7-10.
-
Centers for Disease Control and Prevention. Health Information for the
International Traveler 2001-2002. Atlanta: US Department of Health and Human
Services, Public Health Service, 2001. Disponible en
http://www.cdc.gov/travel
-
American Academy of Pediatrics. Committee on Infectious Diseases.
Recommended Childhood Immunization Schedule - United States, 2002.
Pediatrics 2002;109:162.
-
American Academy of Pediatrics. Committee on Infectious Diseases.
Immunization of Adolescents. Recommendations of the Advisory Committee on
Immunization Practices, the American Academy of Pediatrics, the American
Academy of Family Physicians, and the American Medical Association.
Pediatrics 1997; 99:479-488.
-
Campins M, Moraga FA. Vacunas 1997. Prous Science. Barcelona 1997.
-
Campins M, Moraga FA. Vacunas 1998. Prous Science. Barcelona 1998.
-
Campins M, Moraga FA. Vacunas 1999. Prous Science. Barcelona 1999.
-
Campins M, Moraga FA. Vacunas 2000. Prous Science. Barcelona 2000.
-
Campins M, Moraga FA. Vacunas 2001. Prous Science. Barcelona 2001.
-
Generalitat de Catalunya. Departament de Sanitat i Seguretat Social. Manual
de vacunacions. 3ª ed. Generalitat de Catalunya. Barcelona 2000.
-
Offit P, Quarles J, Gerber M et al.Addressing parent's concerns: Do multiple
vaccines overwhelm or weaken the infant's immune system. Pediatrics
2002;109:124-129.
-
Mallet E, Fabre P, Pines E et al. Immunogenicity and safety of a new liquid
hexavalent combined vaccine compared with separate administration of
reference licensed vaccines in infants. Pediatr Infect Dis J
2000;19:1119-27.
-
CDC. Combination vaccines for childhood immunization: Recommendations of the
Advisory Committee on Immunization Practices, the American Academy of
Pediatrics and the American Academy of Family Physicians. MMWR
1999;48(RR-05):1-15.
-
CDC. Pertussis Vaccination: Use of Acellular Pertussis Vaccine Among Infants
and Young Children. Recomendations of the Advisory Committee on Immunization
Practices (ACIP). MMWR 1997;46(RR-07):1-25
-
Halperin S. Should all adolescents and adults be vaccinated against
pertussis ? Infect Med 2001;18(10):473-475.
-
CDC. Prevention and control of Influenza. MMWR 1999; 48(RR-04):1-28.
-
CDC. Prevention and control of Influenza: Recommendations of the Advisory
Committee on Immunization Practices. MMWR 2000;49(RR-03):1-38.
-
CDC. Prevention and control of Influenza: Recommendations of the Advisory
Committee on Immunization Practices. MMWR 2001;50(RR-04):1-46.
-
CDC. Measdles, mumps and rubella. Vaccine use and strategies for elimination
of measles, rubella and congenital rubella syndrome and control of mumps.
MMWR 1998; 47(RR-08).
-
CDC. Prevention of hepatitis A Through Active or Passive Immunization:
Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR 1999;48(RR-12): 1-37.
-
Generalitat de Catalunya. Departament de Sanitat i Seguretat Social.
Programa per a la vacunació antimeningocòccica conjugada a Catalunya.
Generalitat de Catalunya. Barcelona 2000.
-
CDC. Prevention and Control of Meningococcal Disease: Recommendations of the
Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(RR-07).1-9
-
CDC. Control and prevention of meningococcal disease and control and
prevention of serogroup C meningococcal disease: Evaluation and management
of suspected outbreaks. Recommendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR 1997; 46(RR-05):1-21.
-
National Advisory Committee on Immunization. Statement on recommended use of
meningococcal vaccines. Canada Communicable Disease Report (CCDR)
2001;27(ACS 5,6):2-28.
-
Pollard A, Levin M. Vaccines for prevention of meningococcal disease.
Pediatr Inf Dis J 2000;19:33-345.
-
American Academy of Pediatrics. Committee on Infectious Diseases.
Poliomyelitis Prevention: revised recommendations for use of inactivated and
live oral poliovirus vaccine. Pediatrics 1999; 103:171-172
-
American Academy of Pediatrics. Committee on Infectious Diseases. Prevention
of poliomyelitis: recommendations for use of only inactivated poliovirus
vaccine for routine immunization. Pediatrics 1999; 104:1404-6.
-
CDC. Poliomyelitis Prevention in the United States. Updated recommendations
of the Advisory Committee on Immunization Practices (ACIP). MMWR
2000;49(RR-05):1-22.
-
Salleras Ll. et al. Seroepidemiology of varicella-zoster virus infection in
Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine
2000;19(2-3):183-188.
-
Salleras L, De Aristegui J. Vacunación frente a la varicela: ¿Selectiva o
universal?. Vac Invest Pract 2001;2(supl 1):1-4.
-
CDC. Prevention of varicella: recomendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR 1996; 45(RR-11): 1-36.
-
Chartrand SA. Varicella Vaccine. Ped Clin North America 2000;373-394.
-
CDC. Prevention of Varicella. Updated Recomendations of the Advisory
Committee on Immunization Practices (ACIP). MMWR 1999;48(RR-06):1-5.
-
American Academy of Pediatrics. Committee on Infectious Diseases. Varicella
vaccine update. Pediatrics 2000; 105:136-141.
-
Watson B, Seward J, Yang A et al. Postexposure effectiveness of varicella
vaccine. Pediatrics 2000;105:136-141.
-
Pevention health care, 2001 update: use of varicella vaccine in healthy
populations. CMAJ 2001 94(13):1888-89.
-
Salleras L, Domínguez A, Vidal J, Plans P, Saleras M, Taberner JL.
Seroepidemiology of varicella zoster virus infection in Catalonia (Spain).
Rationale for universal vaccination programmes. Vaccine 2000; 19:183-188.
-
Comité Asesor de Vacunas de la Asociación Española de Pediatría. La
enfermedad neumocócica y su prevención. Vacuna neumocócica conjugada
heptavalente. An esp Pediatr 2002;56:79-90.
-
Casado J, Aristegui J, Rodrigo C et al. Prevalencia de meningitis
neumocócica en niños españoles. An Esp Pediatr 2002;56:5-9.
-
CDC. Prevention of Pneumococcal Disease. Recommendations of the Advisory
Committee on Immunization Practices (ACIP). MMWR 1997; 46(RR-08).1-24.
-
CDC. Preventing Pneumococcal Disease Among Infants and Young Children.
Recommendations of the Advissory Committee on Immunization Practices (ACIP).
MMWR 2000; 49(RR-09):1-38.
-
American Academy of Pediatrics. Committee on Infectious Diseases. Policy
Statement: Recommendations for the Prevention of Pneumococcal Infections,
Including the Use of Pneumococcal Conjugated Vaccine (Prevnar), Pneumococcal
Polysaccharide Vaccine, and Antibiotic Prophylaxis (RE9960). Pediatrics
2000;106:362-366.
-
American Academy of Pediatrics. Committee on Infectious Diseases. Technical
Report: Prevention of Pneumococcal Infections, Including the Use of
Pneumococcal Conjugate and Polysaccharide Vaccines, and Antibiotic
Prophylaxis (RE9960). Pediatrics 2000;106:367-376.
-
Black S, Shinefield H, Fireman B et al. Eficacia, seguridad e
inmunogenicidad de la vacuna conjugada antineumocócica heptavalente en
niños. Pediatr Infect Dis J. 2000;19:187-195.
-
Wuorimaa T, Dagan R, Eskola J et al.
Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate
vaccine in healthy toddlers. Pediatr Infect Dis J. 2001;20:272-277.
-
Giebink G. The prevention of pneumococcal disease in children. N Engl J Med,
2001;16:1177-1183.
-
CDC. The Role of BCG Vaccine in the Prevention and Control of Tuberculosis
in the United States. A Joint Statement of the Advisory Council for the
Elimination of Tuberculosis and the Advisory Committee on Immunization
Practices. MMWR 1996; 45(RR-04):1-14.
-
Shan F, Steinhoff M. Vaccines for children in rich and poor countries.
Lancet 1999;354 (suppl II): 7-11
-
Plotkin SA. Vaccines in the 21st century. Infect Dis Clin North Am.
2001;15:307-324.
